FDA Adverse Event Malfunction Summary report: N

CAPTURE-R READY ID

MDR report key: 1080700 · Received July 25, 2008

Report

Report Number
1034569-2008-00272
Event Type
Malfunction
Date Received
July 25, 2008
Date of Event
June 26, 2008
Report Date
July 17, 2008
Manufacturer
IMMUCOR, INC.
Product Code
KSZ
PMA / PMN Number
102707 STN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

REACTIIVTY OF THE FYA ANTIGEN WAS CONFIRMED ON RETENTION CRRS, LOT K121 AND CRRID, LOT ID079. THE CUSTOMER'S RETURNED SAMPLES WERE TESTED BY HA WITH SELECTED FY(A+B+) AND FY(A-) REAGENT RED CELLS, USING IMMUADD, LOT 5B5503, AS THE POTENTIATOR. VERY WEAK REACTIVITY WAS OBSERVED WITH BOTH SAMPLES WITH FY(A+B+) CELL AT IAT. THE FY(A-) CELL WAS NONREACTIVE, AS EXPECTED. MANUAL SOLID PHASE TESTING WAS PERFORMED WITH THE CUSTOMER'S SAMPLES AND RETENTION CRRS, LOT K121, FY(A+B-) CELL III AND FY(A-) CELL IV AND CRRID, LOT ID079 FY(A+B+) CELL 2; FY(A-B-) CELL 4, AND FY(A+B-) CELL 6. ALL FY(A-) CELLS WERE NONREACTIVE, AS EXPECTED. ONE SAMPLE EXHIBITED VERY WEAK TO WEAK REACTIVITY WITH FY(A+B) CELLS AND NONREACTIVITY WITH FY(A+B+) CELLS. THE OTHER SAMPLE EXHIBITED NEGATIVE TO WEAK REACTIVITY WITH FY(A+B-) CELLS AND NONREACTIVITY WITH FY(A+B+) CELLS. THE CUSTOMER DID NOT RETURN PRODUCT FOR INVESTIGATION. THE PATIENT'S ANTIBODY IS SHOWING DOSAGE EFFECT; THE EVENT APPEARS TO BE CAUSED BY THE NATURE OF THE SAMPLE. THE PACKAGE INSERTS FOR CAPTURE-R READY ID AND CRRS 4 STATE "NEGATIVE REACTIONS WILL BE OBTAINED IF THE TEST SERUM CONTAINS ANTIBODIES PRESENT IN CONCENTRATIONS TOO LOW TO BE DETECTED BY THE TEST METHODS EMPLOYED."

Description of Event or Problem · 1

CUSTOMER REPORTED A FALSE NEGATIVE REACTION WITH CAPTURE R READY SCREEN (CRRS) 4 ON GALILEO. A PATIENT SAMPLE KNOWN TO CONTAIN ANTI-FYA WAS NEGATIVE WHEN TESTED WITH CRRS 4.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CAPTURE-R READY ID REAGENT RED BLOOD CELLS KSZ IMMUCOR, INC. ID079

Patients

Seq Age Sex Outcome Treatment
1